AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 21 filers reported holding AKARI THERAPEUTICS PLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $41,000 | – | 19,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 4,103,098 | $2,585,000 | 3.26% |
| Omnia Family Wealth, LLC | 782,372 | $493,000 | 0.40% |
| ARMISTICE CAPITAL, LLC | 4,290,000 | $2,703,000 | 0.05% |
| Bryn Mawr Capital Management, LLC | 100,000 | $63,000 | 0.02% |
| NEA Management Company, LLC | 452,167 | $285,000 | 0.01% |
| Hikari Power Ltd | 130,821 | $82,000 | 0.01% |
| Truvestments Capital LLC | 1,621 | $1,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 30,264 | $19,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 37,544 | $24,000 | 0.00% |
| Renaissance Technologies | 40,050 | $25,000 | 0.00% |